These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30812058)

  • 1. Mass spectrometric quantification of the binding ratio of metal-based anticancer complexes with protein thiols.
    Han Y; Guo W; Zheng W; Luo Q; Wu K; Zhao Y; Wang F
    Rapid Commun Mass Spectrom; 2019 May; 33(10):951-958. PubMed ID: 30812058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of cisplatin and analogue Pt(en)Cl2 with the copper metallo-chaperone Atox1.
    Sze CM; Shi Z; Khairallah GN; Feketeová L; O'Hair RA; Xiao Z; Donnelly PS; Wedd AG
    Metallomics; 2013 Aug; 5(8):946-54. PubMed ID: 23778981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper binding promotes the interaction of cisplatin with human copper chaperone Atox1.
    Xi Z; Guo W; Tian C; Wang F; Liu Y
    Chem Commun (Camb); 2013 Dec; 49(95):11197-9. PubMed ID: 24150599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study on the interactions of human copper chaperone Cox17 with anticancer organoruthenium(II) complexes and cisplatin by mass spectrometry.
    Li L; Guo W; Wu K; Wu X; Zhao L; Zhao Y; Luo Q; Wang Y; Liu Y; Zhang Q; Wang F
    J Inorg Biochem; 2016 Aug; 161():99-106. PubMed ID: 27235272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between the anticancer drug Cisplatin and the copper chaperone Atox1 in human melanoma cells.
    Palm-Espling ME; Lundin C; Björn E; Naredi P; Wittung-Stafshede P
    Protein Pept Lett; 2014; 21(1):63-8. PubMed ID: 23988033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organometallic ruthenium anticancer complexes inhibit human glutathione-S-transferase π.
    Lin Y; Huang Y; Zheng W; Wang F; Habtemariam A; Luo Q; Li X; Wu K; Sadler PJ; Xiong S
    J Inorg Biochem; 2013 Nov; 128():77-84. PubMed ID: 23942162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrathiomolybdate inhibits the reaction of cisplatin with human copper chaperone Atox1.
    Tian Y; Fang T; Yuan S; Zheng Y; Arnesano F; Natile G; Liu Y
    Metallomics; 2018 May; 10(5):745-750. PubMed ID: 29721562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural biology of cisplatin complexes with cellular targets: the adduct with human copper chaperone atox1 in aqueous solution.
    Calandrini V; Nguyen TH; Arnesano F; Galliani A; Ippoliti E; Carloni P; Natile G
    Chemistry; 2014 Sep; 20(37):11719-25. PubMed ID: 25111319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants for simultaneous binding of copper and platinum to human chaperone Atox1: hitchhiking not hijacking.
    Palm-Espling ME; Andersson CD; Björn E; Linusson A; Wittung-Stafshede P
    PLoS One; 2013; 8(7):e70473. PubMed ID: 23936210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification.
    Dolgova NV; Nokhrin S; Yu CH; George GN; Dmitriev OY
    Biochem J; 2013 Aug; 454(1):147-56. PubMed ID: 23751120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of bindings of organometallic ruthenium complexes to GSTπ by mass spectrometry.
    Lin Y; Huang Y; Zheng W; Wu K; Luo Q; Zhao Y; Xiong S; Wang F
    J Inorg Biochem; 2015 May; 146():44-51. PubMed ID: 25769011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper binding modulates the platination of human copper chaperone Atox1 by antitumor trans-platinum complexes.
    Xi Z; Guo W; Tian C; Wang F; Liu Y
    Metallomics; 2014 Mar; 6(3):491-7. PubMed ID: 24469739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin binds human copper chaperone Atox1 and promotes unfolding in vitro.
    Palm ME; Weise CF; Lundin C; Wingsle G; Nygren Y; Björn E; Naredi P; Wolf-Watz M; Wittung-Stafshede P
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6951-6. PubMed ID: 21482801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of Copper and Cisplatin to Atox1 Is Mediated by Glutathione through the Formation of Metal-Sulfur Clusters.
    Dolgova NV; Yu C; Cvitkovic JP; Hodak M; Nienaber KH; Summers KL; Cotelesage JJH; Bernholc J; Kaminski GA; Pickering IJ; George GN; Dmitriev OY
    Biochemistry; 2017 Jun; 56(24):3129-3141. PubMed ID: 28549213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transferrin serves as a mediator to deliver organometallic ruthenium(II) anticancer complexes into cells.
    Guo W; Zheng W; Luo Q; Li X; Zhao Y; Xiong S; Wang F
    Inorg Chem; 2013 May; 52(9):5328-38. PubMed ID: 23586415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arene control over thiolate to sulfinate oxidation in albumin by organometallic ruthenium anticancer complexes.
    Hu W; Luo Q; Ma X; Wu K; Liu J; Chen Y; Xiong S; Wang J; Sadler PJ; Wang F
    Chemistry; 2009 Jul; 15(27):6586-94. PubMed ID: 19533706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of Human Copper Chaperone Atox1 and Disulfide Bond Cleavage by Cisplatin and Glutathione.
    Nardella MI; Rosato A; Belviso BD; Caliandro R; Natile G; Arnesano F
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platinum transfer from hCTR1 to Atox1 is dependent on the type of platinum complex.
    Wu X; Yuan S; Wang E; Tong Y; Ma G; Wei K; Liu Y
    Metallomics; 2017 May; 9(5):546-555. PubMed ID: 28383086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organometallic ruthenium anticancer complexes inhibit human peroxiredoxin I activity by binding to and inducing oxidation of its catalytic cysteine residue.
    Lin Y; Wang J; Zheng W; Luo Q; Wu K; Du J; Zhao Y; Wang F
    Metallomics; 2019 Mar; 11(3):546-555. PubMed ID: 30693924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactions of an organoruthenium anticancer complex with 2-mercaptobenzanilide--a model for the active-site cysteine of protein tyrosine phosphatase 1B.
    Han Y; Luo Q; Hao X; Li X; Wang F; Hu W; Wu K; Lü S; Sadler PJ
    Dalton Trans; 2011 Nov; 40(43):11519-29. PubMed ID: 21960108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.